No Data
No Data
Guangxi Liuyao Group (603368.SH): Granted 420,700 restricted stocks to 58 incentive targets.
Guangxi Liuyao Group (603368.SH) announced on June 14th that the company's board of directors believes that the restricted stock reserve grant conditions specified in the company's "Incentive Plan" have been achieved, and agreed to set the reservation grant date for the company's 2023 restricted stock incentive plan (referred to as "this incentive plan") as June 14, 2024, with a grant price of 10.22 yuan/share, granting 420,700 restricted stocks to 58 eligible incentive objects.
Guangxi Liuyao Group (603368.SH) annual equity distribution in 2023: 6 yuan per 10 shares, with record date on June 7.
Guangxi Liuyao Group (603368.SH) released the annual equity dividend implementation announcement for 2023. Based on the total equity capital registered on the stock registration date of the equity dividend (excluding shares repurchased and restricted stocks that are intended to be repurchased and cancelled) distributed 6 yuan (tax included) cash dividend to all shareholders for every 10 shares. The ex-dividend date is June 11, 2024, and the record date is June 7, 2024.
Liu Yao Bonds Transfer: Stock conversion will be suspended from June 3 due to 2023 equity distribution
Guangxi Liuyao Group Co., Ltd. announced that due to the implementation of equity distribution in 2023, “Liuyao Bonds Transfer” will stop transferring shares from June 3, 2024 until equity registration for equity distribution resumes at a later date. The share conversion price will be adjusted according to regulations.
Liu Pharmaceutical Group (603368.SH): The total number of pharmacies has reached 841, and plans to open 100 new stores throughout the year and increase the proportion of specialty pharmacies
Liu Yao Group (603368.SH) issued an announcement. On May 18, 2024, the company disclosed “About holding...
Is there no fixed increase in the public offering to invest? The year-on-year decline was nearly 70%. The fixed increase in subscriptions was less than 10 billion dollars. Zhu Shaoxing and Cao Mingchang each lost profits
① The total number of subscriptions to participate in the fixed increase from the public offering this year is only 30% of the same period last year; ② Western Lide and Huian Fund, which rarely “showed up” fixed growth projects, participated in fixed growth projects this year; ③ Cao Mingchang participated in Liuyao Group's fixed growth and fuying exceeded 15%, and Zhu Shaoxing's participation in Qianweiyang Chef's fixed growth and loss was over 15%.
Some directors and executives of Liuyao Group (603368.SH) plan to reduce their holdings by no more than 1.26 million shares
Liu Pharmaceutical Group (603368.SH) announced that Tang Chunxue, director and vice president of the company, plans to reduce his shareholding by no more than 33...
No Data